Folgen
Jens Siveke
Jens Siveke
Bestätigte E-Mail-Adresse bei uni-due.de
Titel
Zitiert von
Zitiert von
Jahr
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open …
A Wang-Gillam, CP Li, G Bodoky, A Dean, YS Shan, G Jameson, ...
The Lancet 387 (10018), 545-557, 2016
11872016
EGF receptor is required for KRAS-induced pancreatic tumorigenesis
CM Ardito, BM Grüner, KK Takeuchi, C Lubeseder-Martellato, ...
Cancer cell 22 (3), 304-317, 2012
5412012
Cutting edge: T helper 1 and T helper 2 cells respond differentially to chemokines
JT Siveke, A Hamann
The Journal of Immunology 160 (2), 550-554, 1998
4081998
Pancreatic cancer: basic and clinical aspects
G Schneider, JT Siveke, F Eckel, RM Schmid
Gastroenterology 128 (6), 1606-1625, 2005
4012005
Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
PK Mazur, A Herner, SS Mello, M Wirth, S Hausmann, FJ Sánchez-Rivera, ...
Nature medicine 21 (10), 1163-1171, 2015
3762015
Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma
PK Mazur, H Einwächter, M Lee, B Sipos, H Nakhai, R Rad, ...
Proceedings of the National Academy of Sciences 107 (30), 13438-13443, 2010
2602010
Liver‐specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice
F Geisler, F Nagl, PK Mazur, M Lee, U Zimber‐Strobl, LJ Strobl, F Radtke, ...
Hepatology 48 (2), 607-616, 2008
2362008
NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors
A Wang-Gillam, RA Hubner, JT Siveke, DD Von Hoff, B Belanger, ...
European Journal of Cancer 108, 78-87, 2019
2312019
S3-guideline exocrine pancreatic cancer
T Seufferlein, M Porzner, T Becker, V Budach, G Ceyhan, I Esposito, ...
Zeitschrift fur Gastroenterologie 51 (12), 1395-1440, 2013
2312013
Th1/Th2 subsets: distinct differences in homing and chemokine receptor expression?
U Syrbe, J Siveke, A Hamann
Springer seminars in immunopathology 21, 263-285, 1999
2211999
Tissue inhibitor of metalloproteinases (TIMP)‐1 creates a premetastatic niche in the liver through SDF‐1/CXCR4‐dependent neutrophil recruitment in mice
B Seubert, B Grünwald, J Kobuch, H Cui, F Schelter, S Schaten, JT Siveke, ...
Hepatology 61 (1), 238-248, 2015
2082015
RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8+ T cells
P Duewell, A Steger, H Lohr, H Bourhis, H Hoelz, SV Kirchleitner, ...
Cell Death & Differentiation 21 (12), 1825-1837, 2014
2022014
Notch signaling is required for exocrine regeneration after acute pancreatitis
JT Siveke, C Lubeseder–Martellato, M Lee, PK Mazur, H Nakhai, ...
Gastroenterology 134 (2), 544-555. e3, 2008
1992008
Concomitant pancreatic activation of KrasG12D and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN
JT Siveke, H Einwächter, B Sipos, C Lubeseder-Martellato, G Klöppel, ...
Cancer cell 12 (3), 266-279, 2007
1872007
Volume assessment in patients with necrotizing pancreatitis: a comparison of intrathoracic blood volume index, central venous pressure, and hematocrit, and their correlation to …
W Huber, A Umgelter, W Reindl, M Franzen, C Schmidt, S Von Delius, ...
Critical care medicine 36 (8), 2348-2354, 2008
1852008
Lineage fate of ductular reactions in liver injury and carcinogenesis
S Jörs, P Jeliazkova, M Ringelhan, J Thalhammer, S Dürl, J Ferrer, ...
The Journal of clinical investigation 125 (6), 2445-2457, 2015
1712015
The latest developments in imaging of fibroblast activation protein
A Altmann, U Haberkorn, J Siveke
Journal of Nuclear Medicine 62 (2), 160-167, 2021
1702021
Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues
M Aichler, C Seiler, M Tost, J Siveke, PK Mazur, P Da Silva‐Buttkus, ...
The Journal of pathology 226 (5), 723-734, 2012
1682012
Comprehensive genomic and transcriptomic analysis for guiding therapeutic decisions in patients with rare cancers
P Horak, C Heining, S Kreutzfeldt, B Hutter, A Mock, J Hüllein, M Fröhlich, ...
Cancer discovery 11 (11), 2780-2795, 2021
1642021
Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction
V Eis, B Luckow, V Vielhauer, JT Siveke, Y Linde, S Segerer, ...
Journal of the American Society of Nephrology 15 (2), 337-347, 2004
1612004
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20